3,6,9,12-Tetraoxatetradecanoic acid, 14-amino-, 95%, 250mg

(R)-Benzyl 2-hydroxy-2-phenylacetate, 98.0%, 5g

2-(3'-BroMo-biphenyl-3-yl)-4,6-diphenyl-[1,3,5]triazine, 97%, 5g

3,5-Diaminophenylboronic acid, 96%, 100mg

tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1-carboxylate, 95.0%, 5g

2,5-Bis-O-[4-[[4-[[[4-(acryloyloxy)butoxy]carbonyl]oxy]benzoyl]oxy]benzoyl]-1,4:3,6-dianhydro-D-glucitol>85.0%(HPLC)1g

Decyltrimethylammonium Bromide>99.0%(T)25g

Chlorure de praséodyme hydraté 99,999% 100 g

tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2), 98%, 250mg

ethyl 2,3-dihydropyrazolo[5,1-b][1,3]oxazole-6-carboxylate, 1g

5-(cyclohexylthio)-2-furaldehyde, 95.0%, 5g

2-(2-Chloroquinazolin-4-yl)acetamide, 95.0%, 5g

Filtres pour seringues Polytétrafluoroéthylène hydrophile (PTFE), 0,22 µm, 25 mm, stérile, 100 pièce(s)